Compile Data Set for Download or QSAR
Report error Found 170 Enz. Inhib. hit(s) with all data for entry = 12801
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729520(US20250101019, Example 33)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729521(US20250101019, Example 34)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729519(US20250101019, Example 32)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729520(US20250101019, Example 33)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729518(US20250101019, Example 31)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729519(US20250101019, Example 32)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729517(US20250101019, Example 30)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729518(US20250101019, Example 31)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729524(US20250101019, Example 37)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729525(US20250101019, Example 38)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729523(US20250101019, Example 36)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729524(US20250101019, Example 37)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729523(US20250101019, Example 36)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729521(US20250101019, Example 34)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729512(US20250101019, Example 25)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729513(US20250101019, Example 26)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729511(US20250101019, Example 24)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729512(US20250101019, Example 25)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729510(US20250101019, Example 23)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729511(US20250101019, Example 24)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729509(US20250101019, Example 22)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729510(US20250101019, Example 23)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729516(US20250101019, Example 29)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729517(US20250101019, Example 30)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729516(US20250101019, Example 29)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729514(US20250101019, Example 27)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729513(US20250101019, Example 26)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729514(US20250101019, Example 27)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729536(US20250101019, Example 49)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729537(US20250101019, Example 50)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729535(US20250101019, Example 48)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729536(US20250101019, Example 49)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729534(US20250101019, Example 47)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729535(US20250101019, Example 48)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729533(US20250101019, Example 46)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729534(US20250101019, Example 47)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729540(US20250101019, Example 53)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729541(US20250101019, Example 54)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729539(US20250101019, Example 52)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729540(US20250101019, Example 53)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729538(US20250101019, Example 51)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729539(US20250101019, Example 52)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729537(US20250101019, Example 50)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729538(US20250101019, Example 51)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729528(US20250101019, Example 41)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729529(US20250101019, Example 42)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729527(US20250101019, Example 40)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729528(US20250101019, Example 41)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729526(US20250101019, Example 39)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 1(Human)
Insilico Medicine IP

US Patent
LigandPNGBDBM729527(US20250101019, Example 40)
Affinity DataIC50: 0.5nMAssay Description:1. Diluted compounds in DMSO by hand for 11 points, 3 folds dilution. Then transferred 0.02 μL compounds to 384 assay plate by ECHO.2. Added 2 μL spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/31/2025
Entry Details
US Patent

Displayed 1 to 50 (of 170 total ) | Next | Last >>
Jump to: